tag:blogger.com,1999:blog-5872673930112727345.post5574045524197103588..comments2024-03-29T09:47:17.107-04:00Comments on Nephron Power: IN THE NEWS:- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.Kenar D Jhaveri( kidney 007)http://www.blogger.com/profile/08654527832183917798noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-5872673930112727345.post-88186779537170574722010-06-27T08:38:01.565-04:002010-06-27T08:38:01.565-04:00The new on this front at the European Society of H...The new on this front at the European Society of Hypertension meeting in Oslo last week was that the addition of the VALUE data to the analysis removed the over-prevalence of new diagnosis cancers. Of related interest is that both beta-blockers and calcium-antagonists went through episodes when they were though to cause cancer, but where more data and more rigorous analysis disproved this. This is probably what we are facing with ARBs too, but that will of course take more data and more analysis. As of today, there is no indication to stop ARB treatment for fear of cancer.Michael Hultströmhttps://www.blogger.com/profile/16994331638255846429noreply@blogger.com